Latest News for Bone Biologics Stock (NASDAQ:BBLG)

Monday, November 20, 2023

Why Bone Biologics Stock (BBLG) Is Falling Sharply
Henry Khederian - Nov 20, 2023, 11:06AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Nov 20, 2023, 8:06AM

Friday, November 17, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Nov 17, 2023, 4:31PM
S&P 500 Edges Higher; Buckle Shares Surge After Q3 Earnings
Lisa Levin - Nov 17, 2023, 2:30PM
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin - Nov 17, 2023, 1:01PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Nov 17, 2023, 12:31PM
Bone Biologics shares are trading lower after the company announced a registered direct offering of 1,139,063 shares at $0.64 per share.
Benzinga Newsdesk - Nov 17, 2023, 12:25PM
Crude Oil Rises Over 3%; BJ's Wholesale Posts Weak Sales
Lisa Levin - Nov 17, 2023, 12:10PM
Why Bone Biologics Stock (BBLG) Is Getting Obliterated Friday
Henry Khederian - Nov 17, 2023, 11:20AM
US Stocks Edge Lower; Housing Starts Rise In October
Lisa Levin - Nov 17, 2023, 9:51AM
Why Gap Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Nov 17, 2023, 8:25AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Nov 17, 2023, 8:06AM

Thursday, November 16, 2023

Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Benzinga Newsdesk - Nov 16, 2023, 4:43PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Nov 16, 2023, 12:31PM
US Stocks Down; Jobless Claims Rise To 231,000
Lisa Levin - Nov 16, 2023, 9:43AM
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Nov 16, 2023, 8:08AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Nov 16, 2023, 8:06AM

Wednesday, November 15, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Nov 15, 2023, 4:31PM

Friday, October 06, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Oct 6, 2023, 9:06AM

Thursday, October 05, 2023

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights - Oct 5, 2023, 5:32PM

Monday, October 02, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Oct 2, 2023, 1:00PM

Tuesday, September 26, 2023

Bone Biologics Anticipates Conducting A 30-patient Pilot Study In Australia, With Plans To Commence The Study Later This Year
Benzinga Newsdesk - Sep 26, 2023, 8:22AM

Thursday, September 21, 2023

Board Member at Bone Biologics Acquires Company Stock Options Worth 85,763 Shares
Benzinga Insights - Sep 21, 2023, 11:03AM
Director at Bone Biologics Acquires Company Stock Options Worth 85,763 Shares
Benzinga Insights - Sep 21, 2023, 11:03AM
Bone Biologics Director Awarded $64K Worth of Stock Options
Benzinga Insights - Sep 21, 2023, 11:03AM

Wednesday, September 13, 2023

Charge Enterprises And 3 Other Stocks Under $1 Insiders Are Buying
Lisa Levin - Sep 13, 2023, 8:57AM

Monday, August 28, 2023

Why LQR House Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 28, 2023, 8:09AM

Wednesday, August 23, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 23, 2023, 1:16PM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Aug 18, 2023, 9:06AM

Thursday, August 17, 2023

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights - Aug 17, 2023, 5:32PM

Tuesday, August 15, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 15, 2023, 1:31PM
Watching Bone Biologics; Zacks Small-Cap Research Sets $7.50 Price Valuation
Happy Mohamed - Aug 15, 2023, 12:04PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Monday, July 31, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Jul 31, 2023, 2:54PM

Wednesday, June 21, 2023

Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
Lisa Levin - Jun 21, 2023, 7:49AM

Tuesday, June 20, 2023

Watching Bone Biologics; Zacks Small-Cap Research Sets $8 Price Valuation
Happy Mohamed - Jun 20, 2023, 10:01AM

Thursday, June 15, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Jun 15, 2023, 2:53PM
Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results
Lisa Levin - Jun 15, 2023, 2:52PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Jun 15, 2023, 1:31PM
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Jun 15, 2023, 1:12PM
Dow Surges Over 300 Points; Kroger Profit Beats Views
Lisa Levin - Jun 15, 2023, 12:06PM
US Stocks Open Higher; Retail Sales Rise In May
Lisa Levin - Jun 15, 2023, 10:15AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM
Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jun 15, 2023, 8:05AM
Bone Biologics shares are trading lower after the company priced its public offering of 2.54M shares At $1.97/share.
Benzinga Newsdesk - Jun 15, 2023, 6:45AM
Bone Biologics Priced An Underwritten Public Offering Of 2.54M Shares At $1.97 Per Share, For Aggregate Gross Proceeds Of Approximately $5M
Benzinga Newsdesk - Jun 15, 2023, 3:31AM

Monday, June 12, 2023

Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin - Jun 12, 2023, 1:03PM

Thursday, June 08, 2023

Watching Bone Biologics; Zacks Small-Cap Research Sets $14.25 Price Valuation; Says BBLG Continues To Pursue A Way To Make Bone Regeneration More Efficient And With Better Outcomes. Co Received Approval For Human Trials, A Step Towards FDA Approval
Happy Mohamed - Jun 8, 2023, 10:07AM

Tuesday, June 06, 2023

Bone Biologics Effects 1-for-30 Reverse Stock Split
Benzinga Newsdesk - Jun 6, 2023, 1:02PM

Wednesday, May 31, 2023

Hearing EF Hutton Initiates Coverage On Bone Biologics With Buy Rating And $2.25 Price Target
Bill Haddad - May 31, 2023, 4:52PM

Open0.444	Close0.440
Vol / Avg.54.393K / 893.507K	Mkt Cap1.799M
Day Range0.438 - 0.454	52 Wk Range0.396 - 13.200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Bone Biologics Stock (NASDAQ:BBLG)

Monday, November 20, 2023

Friday, November 17, 2023

Thursday, November 16, 2023

Wednesday, November 15, 2023

Friday, October 06, 2023

Thursday, October 05, 2023

Monday, October 02, 2023

Tuesday, September 26, 2023

Thursday, September 21, 2023

Wednesday, September 13, 2023

Monday, August 28, 2023

Wednesday, August 23, 2023

Friday, August 18, 2023

Thursday, August 17, 2023

Tuesday, August 15, 2023

Monday, August 14, 2023

Monday, July 31, 2023

Wednesday, June 21, 2023

Tuesday, June 20, 2023

Thursday, June 15, 2023

Monday, June 12, 2023

Thursday, June 08, 2023

Tuesday, June 06, 2023

Wednesday, May 31, 2023